✦ LIBER ✦

Dose-response for subclinical disease—In response to Dr. Ben-Josef

✍ Scribed by H. Rodney Withers; Lester J. Peters; Jeremy M.G. Taylor

Book ID: 103727114
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 266 KB
Volume: 32
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(95)98063-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In response to Drs. Ben-Josef and Kaza

✍ Özer Algan; Gerald E. Hanks; Andrew Shaer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 105 KB

In response to DRS. Ben-Josef and Shamsa

✍ Michael J. Dattoli 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Dose-response relationship for radiation

Dose-response relationship for radiation therapy of subclinical disease

✍ H.Rodney Withers; Lester J. Peters; Jeremy M.G. Taylor 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 875 KB

Response to the letters of Drs. Nori and

Response to the letters of Drs. Nori and Aral and Drs. Ben-Josef and Aref

✍ Frederick B. Stehman; Brian N. Bundy; Gillian M. Thomas 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Dose-induced penile erections in respons

Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease

✍ Jennifer Fine; Anthony E. Lang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Functional COMT variant predicts respons

Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease

✍ Eng-King Tan; Sin-Yun Cheah; Stephanie Fook-Chong; Kenneth Yew; V.R. Chandran; S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

Pyridoxal-5-phosphate, the biological active form of pyridoxine, is a cofactor for dopa-decarboxylase (DDC) enzyme. Pyridoxine may augment the conversion of levodopa to dopamine in the periphery and therefore decrease availability of levodopa to the brain. However, this effect can be negated in the